CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
Preservation of Quality of Life in HER2+ Metastatic Breast Cancer Patients Treated with Tucatinib or Placebo when Added to Trastuzumab and Capecitabine (The HER2CLIMB Trial)
Author
Aithal Sramila
Arkenau Tobias
+29Â more
Block Margaret
Boyle Frances
Brenner Andrew
Cameron David A
Cancel Mathilde
Cold Soeren
Colleoni Marco
Crouzet Laurence
Curigliano Giuseppe
Curtit Elsa
DeBusk Kendra
Fehrenbacher Louis
Feng Wentao
Ferrario Cristiano
Gelmon Karen
Hahn Olwen
Hamilton Erika
Harder Brix Eva
Iqbal Nayyer
Jakobsen Erik
Muñoz-Mateu Montserrat
Müller Volkmar
Paplomata Elizavet
Poosarla Teja
Ramos Jorge
Siadek Muriel
Stringer-Reasor Erica
Wardley Andrew
Zelnak Amelia
Publication venue
'Elsevier BV'
Publication date
29/06/2021
Field of study
Get PDF
Edinburgh Research Explorer
Efficacy of olaparib monotherapy in patients (pts) with HER2-negative metastatic breast cancer (MBC) with germline BRCA
Author
Amanda Woodward
Amber Moran
+14Â more
Cynthia Anne Lynch
Damien Hansra
Daniel W. Nixon
Dennis L. Citrin
Eleanor Meisner
Eugene R Ahn
Joe Ensor
Mary Ninan
Maurie Markman
Rebecca Rollins
Ricardo H. Alvarez
Siraj Mahamed Ali
Sramila S. Aithal
Susan Zook
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref